Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126156911 | 12615691 | 1 | I | 20160217 | 20160223 | 20160802 | 20160802 | EXP | IT-CELGENEUS-ITA-2016025600 | CELGENE | 67.00 | YR | M | Y | 60.00000 | KG | 20160802 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126156911 | 12615691 | 1 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | U | 0 | 1275 | MG | INJECTION FOR INFUSION | QD | ||||||
| 126156911 | 12615691 | 2 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | U | 0 | 750 | MG/M**2 | INJECTION FOR INFUSION | QD | ||||||
| 126156911 | 12615691 | 3 | SS | doxorubicin | DOXORUBICIN | 1 | Intravenous drip | U | 0 | 50 | MG/M**2 | INJECTION FOR INFUSION | QD | ||||||
| 126156911 | 12615691 | 4 | SS | doxorubicin | DOXORUBICIN | 1 | Intravenous drip | U | 0 | 50 | MG/M**2 | INJECTION FOR INFUSION | QD | ||||||
| 126156911 | 12615691 | 5 | SS | Vincristine | VINCRISTINE | 1 | Intravenous drip | U | 0 | 1.4 | MG/M**2 | INJECTION FOR INFUSION | QD | ||||||
| 126156911 | 12615691 | 6 | SS | Vincristine | VINCRISTINE | 1 | Intravenous drip | 30 MILLIGRAM | U | 0 | 1.4 | MG/M**2 | INJECTION FOR INFUSION | QD | |||||
| 126156911 | 12615691 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | U | 0 | 100 | MG | TABLETS | QD | ||||||
| 126156911 | 12615691 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | U | 0 | 100 | MG | TABLETS | QD | ||||||
| 126156911 | 12615691 | 9 | SS | Rituximab | RITUXIMAB | 1 | Intravenous drip | U | 0 | 375 | MG/M**2 | INJECTION FOR INFUSION | |||||||
| 126156911 | 12615691 | 10 | SS | Rituximab | RITUXIMAB | 1 | Intravenous drip | U | 0 | 375 | MG/M**2 | INJECTION FOR INFUSION | |||||||
| 126156911 | 12615691 | 11 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 0 | 30 | MG | UNKNOWN | QD | |||||||
| 126156911 | 12615691 | 12 | C | Filgrastim | FILGRASTIM | 1 | Subcutaneous | 0 | 30 | IU | UNKNOWN | ||||||||
| 126156911 | 12615691 | 13 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 160/180 | 0 | UNKNOWN | BIW | ||||||||
| 126156911 | 12615691 | 14 | C | Cardioaspirin | ASPIRIN | 1 | Oral | 300 MILLIGRAM | 0 | 100 | MG | UNKNOWN | QD | ||||||
| 126156911 | 12615691 | 15 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 1 GRAM | 0 | 300 | MG | UNKNOWN | QD | ||||||
| 126156911 | 12615691 | 16 | PS | CC-5013 | LENALIDOMIDE | 1 | Oral | U | U | 60100 | 15 | MG | CAPSULES | QD | |||||
| 126156911 | 12615691 | 17 | SS | CC-5013 | LENALIDOMIDE | 1 | Oral | U | U | 60100 | 15 | MG | CAPSULES | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126156911 | 12615691 | 1 | Diffuse large B-cell lymphoma |
| 126156911 | 12615691 | 3 | Diffuse large B-cell lymphoma |
| 126156911 | 12615691 | 5 | Diffuse large B-cell lymphoma |
| 126156911 | 12615691 | 7 | Diffuse large B-cell lymphoma |
| 126156911 | 12615691 | 9 | Diffuse large B-cell lymphoma |
| 126156911 | 12615691 | 11 | Gastritis prophylaxis |
| 126156911 | 12615691 | 12 | Prophylaxis |
| 126156911 | 12615691 | 13 | Prophylaxis |
| 126156911 | 12615691 | 14 | Prophylaxis |
| 126156911 | 12615691 | 15 | Prophylaxis |
| 126156911 | 12615691 | 16 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126156911 | 12615691 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126156911 | 12615691 | Bile duct stone | |
| 126156911 | 12615691 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126156911 | 12615691 | 1 | 20160115 | 0 | ||
| 126156911 | 12615691 | 2 | 20160205 | 0 | ||
| 126156911 | 12615691 | 3 | 20160115 | 0 | ||
| 126156911 | 12615691 | 4 | 20160205 | 20160205 | 0 | |
| 126156911 | 12615691 | 5 | 20160115 | 0 | ||
| 126156911 | 12615691 | 6 | 20160205 | 20160205 | 0 | |
| 126156911 | 12615691 | 7 | 20160115 | 0 | ||
| 126156911 | 12615691 | 8 | 20160205 | 20160209 | 0 | |
| 126156911 | 12615691 | 9 | 20160114 | 0 | ||
| 126156911 | 12615691 | 10 | 20160204 | 20160204 | 0 | |
| 126156911 | 12615691 | 11 | 20160114 | 0 | ||
| 126156911 | 12615691 | 12 | 20160121 | 0 | ||
| 126156911 | 12615691 | 13 | 20160114 | 0 | ||
| 126156911 | 12615691 | 14 | 20160114 | 20160301 | 0 | |
| 126156911 | 12615691 | 15 | 20160114 | 20160301 | 0 | |
| 126156911 | 12615691 | 16 | 20160115 | 0 | ||
| 126156911 | 12615691 | 17 | 20160205 | 20160217 | 0 |